The ability of TGF-β to activate Smad signaling has a significant role in TGF-β-induced EMT, a process that, when disorganized, plays a major role in a wide array of pathologic disorders, including fibrotic diseases and cancer [39, 40]. Here, TGFB1 is linked to cancer.